Evidence map›Paper›PMID 36222215›Full record

ArticleJournal of cachexia, sarcopenia and muscle2022

A prospective clinical study on the mechanisms underlying critical illness myopathy-A time-course approach.

Nicola Cacciani, Åsa Skärlén, Ya Wen, Xiang Zhang, Alex B Addinsall, Monica Llano-Diez, Meishan Li, Lennart Gransberg, Yvette Hedström, Bo-Michael Bellander and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07017517 (Effect of Physical Therapy on NLRP3 Inflammasome Activation and Muscle Atrophy in Critical Illness Myopathy), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07017517 narecruitingnot on this mapstarted 2026, after this paper: background citation

Effect of Physical Therapy on NLRP3 Inflammasome Activation and Muscle Atrophy in Critical Illness Myopathy (PT-NLRP3-CIM).

TypeinterventionalSponsorUniversity of ChileRan2026 to 2027Enrolled24ConditionsCritical Illness MyopathyArmsMotomed Letto® servo-assisted cycling + standard physiotherapy, Standard physiotherapy
3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. 'Cells · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nicola CaccianiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Åsa SkärlénDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Ya WenDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Xiang ZhangDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Alex B AddinsallDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Monica Llano-DiezDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Meishan LiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Lennart GransbergDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Yvette HedströmDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Bo-Michael BellanderSection of Neurosurgery, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
David NelsonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Jonas BergquistAnalytical Chemistry and Neurochemistry, Department of Chemistry-Biomedical Centre, Uppsala University, Uppsala, Sweden.
Lars LarssonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-3722-035X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCritical illness myopathy (CIM) is a consequence of modern critical care resulting in general muscle wasting and paralyses of all limb and trunk muscles, resulting in prolonged weaning from the ventilator, intensive care unit (ICU) treatment and rehabilitation. CIM is associated with severe morbidity/mortality and significant negative socioeconomic consequences, which has become increasingly evident during the current COVID-19 pandemic, but underlying mechanisms remain elusive.

methodsTen neuro-ICU patients exposed to long-term controlled mechanical ventilation were followed with repeated muscle biopsies, electrophysiology and plasma collection three times per week for up to 12 days. Single muscle fibre contractile recordings were conducted on the first and final biopsy, and a multiomics approach was taken to analyse gene and protein expression in muscle and plasma at all collection time points.

results(i) A progressive preferential myosin loss, the hallmark of CIM, was observed in all neuro-ICU patients during the observation period (myosin:actin ratio decreased from 2.0 in the first to 0.9 in the final biopsy, P < 0.001). The myosin loss was coupled to a general transcriptional downregulation of myofibrillar proteins (P < 0.05; absolute fold change >2) and activation of protein degradation pathways (false discovery rate [FDR] <0.1), resulting in significant muscle fibre atrophy and loss in force generation capacity, which declined >65% during the 12 day observation period (muscle fibre cross-sectional area [CSA] and maximum single muscle fibre force normalized to CSA [specific force] declined 30% [P < 0.007] and 50% [P < 0.0001], respectively). (ii) Membrane excitability was not affected as indicated by the maintained compound muscle action potential amplitude upon supramaximal stimulation of upper and lower extremity motor nerves. (iii) Analyses of plasma revealed early activation of inflammatory and proinflammatory pathways (FDR < 0.1), as well as a redistribution of zinc ions from plasma.

conclusionsThe mechanical ventilation-induced lung injury with release of cytokines/chemokines and the complete mechanical silencing uniquely observed in immobilized ICU patients affecting skeletal muscle gene/protein expression are forwarded as the dominant factors triggering CIM.

Indexed as

Muscular DiseasesVentilator-Induced Lung InjuryChemokinesCritical IllnessCytokinesHumansMultiomicsMyosinsProspective StudiesRespiration, ArtificialChemokinesCytokinesMyosinscritical illness myopathymechanical ventilationmembrane exitabilitymuscle paresismyosin loss

Identifiers

PMID36222215
PMCPMC9745499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.